Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor ? (IL2RG) gene promoter - 04/03/16

Anita Chandra, MRCP, FRCPath, PhD ^{a, b, f,} ∗

  These authors contributed equally to this work.

, Fang Zhang, PhD ^c, ∗

  These authors contributed equally to this work.

, Kimberly C. Gilmour, FRCPath, PhD ^d, David Webster, FRCPath ^e, Vincent Plagnol, PhD ^h, Dinakantha S. Kumararatne, FRCPath, DPhil ^a, Siobhan O. Burns, MB, PhD, MRCPI(Paeds) ^{e, i}, Sergey Nejentsev, MD, PhD ^f, Adrian J. Thrasher, MRCP, PhD ^{c, g}

^a Department of Clinical Biochemistry and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom 

^b Lymphocyte Signalling & Development, Babraham Institute, Cambridge, United Kingdom 

^c Molecular and Cellular Immunology, Institute of Child Health, University College London, London, United Kingdom 

^d Department of Immunology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom 

^e University College London Institute of Immunity and Transplantation, London, United Kingdom 

^f Department of Medicine, University of Cambridge, Cambridge, United Kingdom 

^g Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom 

^h University College London Genetics Institute, University College London, London, United Kingdom 

ⁱ Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom